B. Lall Pharma Private Limited, a active private limited company, was established on 01 April 2020 in Delhi, Delhi, India. Engaging in chemical distribution & retail within the chemicals and materials sector, it holds CIN: U24230DL2020PTC363122. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.90 M.
Its leadership includes Anil Mediratta (Director), Rohit Mediratta (Director), Sunil Mediratta (Director). It holds ₹1.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1581/3-4 Bhagirath Palace Chandani Chowk, Delhi, Delhi, 110006.
U24230DL2020PTC363122
363122
01 April 2020
₹1.50 M
₹0.90 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into B. Lall Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Mediratta | Director | 01 Apr 2020 | Current |
| Rohit Mediratta | Director | 01 Apr 2020 | Current |
| Sunil Mediratta | Director | 01 Apr 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
B. Lall Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 142.37% increase. The company also saw a substantial improvement in profitability, with a 58.49% increase in profit. The company's net worth Soared by an impressive increase of 67.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to B. Lall Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2022 | Others | ₹1.70 M | Open |
Explore comprehensive loan charge details -
B. Lall Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of B. Lall Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B. Lall Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity B. Lall Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
B. Lall Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.70 M with Charge ID 100645561 was registered on 03 Dec 2022. was documented.
The activity Anil Mediratta was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 8 months . was completed.
Rohit Mediratta was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.
Progress on Sunil Mediratta was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 8 months . was documented.
The CIN of B. Lall Pharma Private Limited is U24230DL2020PTC363122.
B. Lall Pharma Private Limited is headquartered at 1581/3-4 Bhagirath Palace Chandani Chowk, Delhi, Delhi, 110006.
B. Lall Pharma Private Limited was incorporated on 01 April 2020.
The current directors of B. Lall Pharma Private Limited are
The primary industry of B. Lall Pharma Private Limited is Chemicals And Materials.
B. Lall Pharma Private Limited is unlisted.
The authorized capital of B. Lall Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.90 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX